PortViewPortView
Eloxx Pharmaceuticals logo

Eloxx Pharmaceuticals (ELOX) Stock Analysis

NASDAQHealthcareBiotechnology

$15.57+3.73%
1-year price historyRange $0.00 – $20.98
52-week range$15.57
$8.20$23.40

What Eloxx Pharmaceuticals does

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-rare genetic diseases that arise from premature stop codons. The company's most advanced investigational compound, ELX-02, is currently progressing through Phase 2 clinical trials. This candidate is being evaluated for its potential to treat patients with cystic fibrosis and nephropathic cystinosis who possess diagnosed nonsense mutations. In addition to its lead program, Eloxx is actively pursuing several preclinical projects aimed at conditions like Alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis. The company also maintains various earlier-stage discovery initiatives focused on oncology. Eloxx Pharmaceuticals was established in 2013 and is headquartered in Watertown, Massachusetts.

Key metrics

Market cap
$53.50M
P/E (TTM)
-0.37
EPS (TTM)
$-41.80
Beta
-9.95
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$14.82
200-day avg
$14.55
52-week high
$23.40
52-week low
$8.20
CEO
Sumit Aggarwal

ETFs linked to ELOX

Broad-market and Healthcare sector ETFs an investor holding Eloxx Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ELOX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ELOX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals trades under the ticker ELOX on NASDAQ.
Which exchange is ELOX listed on?
ELOX is listed on NASDAQ.
What sector does Eloxx Pharmaceuticals operate in?
Eloxx Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ELOX in a portfolio?
PortView shows ELOX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.